Eleven-Year Trends in Lipid-Modifying Medicines Utilisation and Expenditure in a Low-Income Country: A Study from the Republic of Srpska, Bosnia and Herzegovina.

Clinicoecon Outcomes Res · 2023 · PMC10317530 · PMID 37405360

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

Related to the total lipid-modifying medicines expenditure, the expenditure for simvastatin had a negative trend with a decrease in share from 42.62% in 2010 to 4.77% in 2020.

also in 2,480 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.